Showing results (2651-2660 of 2,860) with videos related to
Sort By:
Pageof 286
Neuropsychobiology|May 27, 2009
Stress influences brain enkephalinase, oxytocinase and angiotensinase activities: a new hypothesisJoaquin Hernández, Ana B Segarra, Manuel Ramírez, et al.Neuropsychobiology|May 15, 2009
The impact of heat shock protein 70 gene variations on clinical presentation and outcome in schizophrenic inpatientsChi-Un Pae, Antonio Drago, Jung-Jin Kim, et al.Neuropsychobiology|May 15, 2009
Cocaine use disorders and serum magnesium profileF Tonioni, G Martinotti, A Barra, et al.Neuropsychobiology|October 4, 2008
Cytokine Genes TNF, IL1A, IL1B, IL6, IL1RN and IL10, and childhood-onset mood disordersV L Misener, L Gomez, K G Wigg, et al.Neuropsychobiology|August 23, 2005
Monoamine oxidase activity and tri-iodothyronine level in violent offenders with early behavioural problemsJenny Eklund, Per Olof Alm, Britt af KlintebergNeuropsychobiology|July 23, 2005
Catechol-O-methyltransferase Val158Met polymorphism in schizophrenia: associations with cognitive and motor impairmentSilvana Galderisi, Mario Maj, Brian Kirkpatrick, et al.Neuropsychobiology|October 19, 2007
Alcohol consumption is associated with an interaction between DRD2 exon 8 A/A genotype and self-directedness in malesMichael Lucht, Sven Barnow, Winnie Schroeder, et al.Neuropsychobiology|November 27, 2007
Monocytic, Th1 and th2 cytokine alterations in the pathophysiology of schizophreniaKyeong-Sae Na, Yong-Ku KimNeuropsychobiology|November 27, 2007
Nicotine effects on mismatch negativity in nonsmoking schizophrenic patientsRie Inami, Eiji Kirino, Reiichi Inoue, et al.Neuropsychobiology|January 3, 2007
Increased omega complexity and decreased microstate duration in nonmedicated schizophrenic patientsSatoshi Irisawa, Toshiaki Isotani, Takami Yagyu, et al.Pageof 286